Drug Development

May 23, 2018
By BioPharm International Editors
The new company will develop proprietary RNA-based therapeutics and will provide broad lentiviral development and manufacturing expertise and support.
May 17, 2018
By BioPharm International Editors
The FDA commissioner released a statement expressing the agency’s plan to address tactics used by pharma companies to delay generic-drug competition.
May 16, 2018
By BioPharm International Editors
Valerius Biopharma will use Catalent’s GPEx technology to produce cell lines for biosimilar drugs.
May 07, 2018
Smaller review divisions will bring experts closer to decision processes and reduce bottlenecks, FDA leaders say.
May 01, 2018
BioPharm International
Process understanding and careful assessment of risks are essential in developing viral clearance programs.
May 01, 2018
BioPharm International
More published data and initial regulatory approvals are needed to drive adoption of continuous bio-manufacturing.
May 01, 2018
BioPharm International
While technology promises advances for healthcare, a skilled workforce is needed to deliver on the potential.
May 01, 2018
BioPharm International
A validation plan developed to support a process unrelated to bio-pharmaceutical manufacture is applied to biopharmaceutical processes and systems.
Apr 24, 2018
By BioPharm International Editors
Research from Gladstone Institutes suggests that transplanting genetically altered interneurons could improve cognitive function for Alzheimer’s disease.
Apr 24, 2018
By BioPharm International Editors
Scientists at Washington University School of Medicine in St. Louis have developed a new method that could help increase the long-term effectiveness of gene therapy.
native1_300x100
lorem ipsum